You can buy or sell Mitsui & Co. and other stocks, options, ETFs, and crypto commission-free!
Mitsui & Co., Ltd. engages in the general trading business. It operates through the following segments: Iron and Steel Products; Mineral and Metal Resources; Machinery and Infrastructure; Chemicals; Energy; Lifestyle; Innovation and Corporate Development; Overseas; and Others. Read More The Iron and Steel Products segment manages the sourcing and supply of iron and steel products; investment in steel service centers; electric furnace steel mills, rolling mills, component manufacturers; and the iron and steel distribution industry. The Mineral and Metal Resources segment handles investment in resource development, production, processing, and trading business; and the environmental recycling business. The Machinery and Infrastructure segment upgrades and maintains infrastructure to facilitate social and economic development through projects in fields such as power generation, energy and mineral resources, marine energy, water supply, and logistics. The Chemicals segment manufactures, trades and sells chemical products in Japan and overseas. The Energy segment explores, develops, produces, and trades energy resources. The Lifestyle segment deals with global sales of food resources and products. The Innovation and Corporate Development segment undertakes information technology, financial technology, and logistics technology services. The Overseas segment engages in the sales and intermediary service of various commodities and conducts related businesses led by overseas trading subsidiaries and their affiliated companies in their respective countries including America, Europe, the Middle East, and Africa (EMEA), and Asia-Pacific. The Others segment includes corporate staff department performing financial business services. The company was founded on July 1, 1876 and is headquartered in Tokyo, Japan. MITSY is listed on the Pink Current market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com).
52 Week High
52 Week Low
TriNetX Secures $40 Million in Series D Funding
CAMBRIDGE, Mass., March 13, 2019 /PRNewswire/ -- TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE), has secured $40 million in Series D financing bringing its total funding to $102 million. The oversubscribed round was led by Merck Global Health Innovation Fund (Merck GHIF) along with new investors Mitsui & Co., Ltd., ITOCHU Technology Ventures, ITOCHU Corporation, and existing investors MPM Capital, ...
Nikkei Asian ReviewMar 4
Russia's Arctic LNG project aims to tempt fuel-hungry Japan
TOKYO -- Russia's push for Japanese participation in an Arctic energy project comes as the world's largest natural gas exporter, faced with the rise of the U.S. as a rival, looks to Asia to diversify.
Nikkei Asian ReviewFeb 20